Year |
Citation |
Score |
2023 |
Alexander SPH, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Buneman OP, Faccenda E, Harding SD, Spedding M, Cidlowski JA, Fabbro D, Davenport AP, Striessnig J, Davies JA, ... ... Bodle C, et al. The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets. British Journal of Pharmacology. S1-S22. PMID 38123153 DOI: 10.1111/bph.16176 |
0.665 |
|
2021 |
Alexander SP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, Fabbro D, ... ... Bodle C, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets. British Journal of Pharmacology. 178: S1-S26. PMID 34529830 DOI: 10.1111/bph.15537 |
0.663 |
|
2020 |
Ahlers-Dannen KE, Alqinyah M, Bodle C, Bou Dagher J, Chakravarti B, Choudhuri SP, Druey KM, Fisher RA, Gerber KJ, Hepler JR, Hooks SB, Kantheti HS, Karaj B, Lee J, Luo Z, et al. Regulators of G protein Signaling (RGS) proteins (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2020. DOI: 10.2218/gtopdb/f891/2020.5 |
0.744 |
|
2020 |
Ahlers-Dannen KE, Alqinyah M, Bodle C, Bou Dagher J, Chakravarti B, Choudhuri SP, Druey KM, Fisher RA, Gerber KJ, Hepler JR, Hooks SB, Kantheti HS, Karaj B, Lee J, Luo Z, et al. Regulators of G protein Signaling (RGS) proteins (version 2020.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2020. DOI: 10.2218/gtopdb/f891/2020.4 |
0.744 |
|
2019 |
Alqinyah M, Bodle C, Bou Dagher J, Chakravarti B, Choudhuri SP, Druey KM, Fisher RA, Gerber KJ, Hepler JR, Hooks SB, Kantheti HS, Karaj B, Lee J, Luo Z, Martemyanov K, et al. Regulators of G protein Signaling (RGS) proteins (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f891/2019.4 |
0.756 |
|
2018 |
Bodle CR, Schamp JH, O'Brien JB, Hayes MP, Wu M, Doorn JA, Roman DL. Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical Substructures. Slas Discovery : Advancing Life Sciences R & D. 2472555217752301. PMID 29351497 DOI: 10.1177/2472555217752301 |
0.779 |
|
2017 |
Hayes MP, Bodle CR, Roman DL. Evaluation of the Selectivity and Cysteine-Dependence of Inhibitors Across the Regulator of G Protein Signaling Family. Molecular Pharmacology. PMID 29051318 DOI: 10.1124/mol.117.109843 |
0.774 |
|
2017 |
Bodle CR, Mackie DI, Hayes MP, Schamp JH, Miller MR, Henry MD, Doorn JA, Houtman JCD, James MA, Roman DL. Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell Lines. Journal of Natural Products. PMID 28621943 DOI: 10.1021/acs.jnatprod.7b00112 |
0.677 |
|
2017 |
Bodle CR, Hayes MP, O'Brien JB, Roman DL. "Development of bimolecular luminescence complementation assay for RGS: G protein interactions in cells." Analytical Biochemistry. PMID 28115169 DOI: 10.1016/j.ab.2017.01.013 |
0.767 |
|
2013 |
Bodle CR, Mackie DI, Roman DL. RGS17: an emerging therapeutic target for lung and prostate cancers. Future Medicinal Chemistry. 5: 995-1007. PMID 23734683 DOI: 10.4155/Fmc.13.91 |
0.752 |
|
Show low-probability matches. |